Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,896.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 2,120.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 350,964
  • Market Cap: £4,206.97m
  • RiskGrade: 125

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 20 Feb 2020

LONDON (ShareCast) - (Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.

Hochschild Mining: Berenberg reiterates hold with a target price of 190p.

Morgan Sindall: Liberum reiterates hold with a target price of 1,850p.

Spectris: Liberum reiterates hold with a target price of 2,400p.

Rathbone Brothers: Liberum reiterates hold with a target price of 2,100p.

Mondi: Deutsche Bank reiterates buy with a target price of 1,950p.

Meggitt: Credit Suisse reiterates underperform with a target price of 520p.

AstraZeneca: Barclays reiterates overweight with a target price of 8,500p.

GlaxoSmithKline: Barclays reiterates underweight with a target price of 1,550p.

Hikma Pharmaceuticals: Barclays reiterates equal weight with a target price of 1,900p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,896.00p
Change Today 19.00p
% Change 1.01 %
52 Week High 2,120.00p
52 Week Low 1,722.00p
Volume 350,964
Shares Issued 221.89m
Market Cap £4,206.97m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average43.84% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Price Trend
19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average19.79% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average16.04% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 21-Mar-24
Paid 20-Sep-24 03-May-24
Amount 32.00¢ 47.00¢

Trades for 27-Sep-2024

Time Volume / Share Price
17:19 146,027 @ 1,882.00p
16:53 411 @ 1,896.00p
16:53 2,246 @ 1,896.00p
16:35 266 @ 1,896.00p
16:35 153,088 @ 1,896.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page